Herborium Group, Inc.
HBRM
Rank in Stocks
#34439
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics,... Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea. The company also offers the AcnEase Skin Management System, intended to diminish acne marks and scars. Furthermore, Herborium provides non-prescription sexual health and performance products. These serve as alternatives for specific sexual dysfunctions that may arise from cardiovascular conditions, the use of antidepressants, or surgical procedures such as hysterectomies. The company also offers energy-boosting products, notably Lasting Energy. This herbal supplement aims to reduce hangover effects, counteract jet lag, and address general energy depletion caused by intense physical activities, high stress levels, prolonged sexual engagements, or other enduring or temporary physical demands. Additional products in its portfolio include the Liver Activator Series for managing liver damage; ProstAid, a natural remedy specifically formulated for Benign Prostate Hyperplasia (BPH); and CardioVitae, a fermentation-based product utilizing a Lucidium-derived cell line to target cardio-pulmonary insufficiencies. Herborium Group, Inc. distributes its products across the United States, the United Kingdom, and mainland Europe, utilizing a network of distributors, specialty retailers, and its e-commerce platform. The company was founded in 2000 and has its principal office located in Fort Lee, New Jersey.
Share Price
$0.000001
Last synced: 2026-11-12
Market Cap
$10.92K
Change (1 day)
-99.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Herborium Group, Inc. (HBRM)
Category
Healthcare
EPS for Herborium Group, Inc. (HBRM)
EPS as of August 2026 TTM: 0.00
According to Herborium Group, Inc.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Herborium Group, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | -100.00% |
| 2007 | $-5.68 | 81.47% |
| 2006 | $-3.13 | -98.27% |
| 2004 | $-180.47 | -11.09% |
| 2003 | $-202.99 | -24.95% |
| 2002 | $-270.47 | -2.47% |
| 2001 | $-277.31 | -2,873.10% |
| 2000 | $10.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | - |
DE
|
|
| $6.01 | - |
DE
|
|
| $1.53 | - |
JP
|
|
| $3.66 | - |
CH
|
|
| $0.45 | - |
IL
|
Questions about Herborium Group, Inc.'s earnings per share (EPS)
What was Herborium Group, Inc.'s earnings per share (EPS) in 2025?
In 2025, Herborium Group, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Herborium Group, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Herborium Group, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Herborium Group, Inc.'s earnings per share (EPS) compare with similar companies?
Herborium Group, Inc.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.